Disruption of Endothelial Cell Mitochondrial Bioenergetics in Lambs with Increased Pulmonary Blood Flow

Autor: Sohrab Fratz, Stephen M. Black, Shruti Sharma, Monique Radman, Ruslan Rafikov, Saurabh Aggarwal, Sridevi Dasarathy, Tantiana Burns, Qing Lu, Christian Schreiber, Jeffrey R. Fineman, Johnny Wright, Sanjiv Kumar, Xutong Sun, Olga Rafikova
Rok vydání: 2013
Předmět:
Pulmonary Circulation
Physiology
Clinical Biochemistry
Medical Biochemistry and Metabolomics
Mitochondrion
Cardiovascular
Biochemistry
Congenital
chemistry.chemical_compound
Adenosine Triphosphate
Enos
Homeostasis
Lung
Heart Defects
General Environmental Science
Forum Original Research Communications
biology
Nitric Oxide Synthase Type III
Pulmonary
Pharmacology and Pharmaceutical Sciences
Mitochondria
Nitric oxide synthase
Hypertension
Signal Transduction
medicine.drug
Heart Defects
Congenital

Biochemistry & Molecular Biology
medicine.medical_specialty
Hypertension
Pulmonary

Nitric Oxide
Arginine
Nitric oxide
Carnitine
Internal medicine
medicine
Animals
Molecular Biology
Sheep
Animal
Endothelial Cells
Cell Biology
biology.organism_classification
Disease Models
Animal

Endocrinology
chemistry
Regional Blood Flow
Disease Models
biology.protein
General Earth and Planetary Sciences
Biochemistry and Cell Biology
Asymmetric dimethylarginine
Zdroj: Antioxidants & redox signaling, vol 18, iss 14
ISSN: 1557-7716
1523-0864
DOI: 10.1089/ars.2012.4806
Popis: Aims: The mitochondrial dysfunction in our lamb model of congenital heart disease with increased pulmonary blood flow (PBF) (Shunt) is associated with disrupted carnitine metabolism. Our recent studies have also shown that asymmetric dimethylarginine (ADMA) levels are increased in Shunt lambs and ADMA increases the nitration of mitochondrial proteins in lamb pulmonary arterial endothelial cells (PAEC) in a nitric oxide synthase (NOS)-dependent manner. Thus, we determined whether there was a mechanistic link between endothelial nitric oxide synthase (eNOS), ADMA, and the disruption of carnitine homeostasis in PAEC. Results: Exposure of PAEC to ADMA induced the redistribution of eNOS to the mitochondria, resulting in an increase in carnitine acetyl transferase (CrAT) nitration and decreased CrAT activity. The resulting increase in acyl-carnitine levels resulted in mitochondrial dysfunction and the disruption of mitochondrial bioenergetics. Since the addition of l-arginine prevented these pathologic changes, we examined the effect of l-arginine supplementation on carnitine homeostasis, mitochondrial function, and nitric oxide (NO) signaling in Shunt lambs. We found that the treatment of Shunt lambs with l-arginine prevented the ADMA-mediated mitochondrial redistribution of eNOS, the nitration-mediated inhibition of CrAT, and maintained carnitine homeostasis. In turn, adenosine-5′-triphosphate levels and eNOS/heat shock protein 90 interactions were preserved, and this decreased NOS uncoupling and enhanced NO generation. Innovation: Our data link alterations in cellular l-arginine metabolism with the disruption of mitochondrial bioenergetics and implicate altered carnitine homeostasis as a key player in this process. Conclusion: l-arginine supplementation may be a useful therapy to prevent the mitochondrial dysfunction involved in the pulmonary vascular alterations secondary to increased PBF. Antioxid. Redox Signal. 18, 1739–1752.
Databáze: OpenAIRE